Analysis
Life sciences and health care M&A Update: Q2 2024
Amid capital market uncertainties, life sciences companies are working to ensure they are ready for IPOs and M&A transactions once market challenges abate.
Life sciences and health care trends
- Health care services
The advent of AI-powered clinics-in-a-box, with features like biometric body scans and virtual doctor consultations, is set to revolutionize health care delivery in the long term.1
- Health care technology
AI’s use in health care is expected to grow 37.5% annually through 2030 and exceed $200 billion in value.2
- Life sciences and pharma services
Despite uncertainties, industry analysts are cautiously optimistic about 2024 with expected sustained M&A activity and potential IPO resurgence in the latter half of the year.3
- Medical devices and supplies
Digital therapeutic devices are set to grow by 29.8% annually in the United States through 2025, driven by increased demand for at-home diagnostics and self-testing.4
- Payors and payor services
Payers are grappling with rising costs from expensive therapies and labor shortages, potentially increasing employer insurance rates by 9% by 2024..5
This newsletter is a periodic compilation of certain capital markets information.
References
1 Bernard Marr, “The 10 biggest trends revolutionizing healthcare in 2024,” Forbes, October 3, 2023.
2 Dan Ketchum, “Healthcare M&A: Market trends & opportunities to know for 2024,” CapLinked, March 14, 2024.
3 Barbara Tague, “M&A in healthcare: 2024 outlook,” AlphaSense, March 13, 2024.
4 Rhoena Endaya, “8 technology-driven healthcare trends in 2024,” LiveSwitch, June 26, 2024.
5 Monisha Machado-Pereira, “2024 payers outlook: Opportunities abound,” McKinsey & Company, December 18, 2023.
Previous editions
- Life Sciences & Health Care M&A quarterly update: Q1 2024
- Life Sciences & Health Care M&A quarterly update: Q4 2023
- Life Sciences & Health Care M&A quarterly update: Q3 2023
- Life Sciences & Health Care M&A quarterly update: Q2 2023
- Life Sciences & Health Care M&A quarterly update: Q1 2023
- Life Sciences & Health Care M&A quarterly update: Q3 2022
- Life sciences and health care M&A update: Q2 2022
- Life sciences and health care M&A update: Q1 2022
- Life sciences and health care M&A update: Q4 2021
- Life sciences and health care M&A update: Q2 2021
- Life sciences and health care M&A update: Q1 2021
- Life sciences & health care M&A update: Q4 2020
- Life sciences & health care M&A update: Q2 2020
- Life sciences & health care M&A update: Q1 2020
- Life sciences & health care M&A update: Q4 2019
- Life sciences & health care M&A update: Q2 2019
- Life sciences & health care M&A update: Q1 2019
- Life sciences & health care M&A update: Q4 2018
- Life sciences & health care M&A update: Q3 2018
- Life sciences & health care M&A update: Q2 2018
- Life sciences & health care M&A update: Q1 2018
- Life sciences & health care M&A update: Q4 2017
- Life sciences & health care M&A update: Q3 2017
- Life sciences & health care M&A update: Q2 2017
- Life sciences & health care M&A update: Q4 2016